PUMA BIOTECHNOLOGY, INC.
Develops and commercializes innovative cancer therapeutics, with an approved drug and a clinical pipeline.
PBYI | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74587V1070
- LEI:
- Country:
- United States of America
- Address:
- 10880 WILSHIRE BLVD., 90024 LOS ANGELES
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of innovative products and novel therapeutics to enhance cancer care. The company's portfolio includes an FDA-approved treatment for cancer. Its clinical pipeline features alisertib, an investigational drug undergoing clinical trials for small cell lung cancer (ALISCA™-Lung1) and metastatic breast cancer (ALISCA™-Breast1).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PUMA BIOTECHNOLOGY, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PUMA BIOTECHNOLOGY, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PUMA BIOTECHNOLOGY, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
